Antimicrobial resistance in European Hospitals

ecoc In 2011 and 2012, ECDC coordinated the first EU-wide point prevalence survey (PPS) to collect data on healthcare-associated infections (HAIS) and on antimicrobial use in European hospitals. All countries used the same standardised protocol that had been developed during a two-year collaborative effort involving more than 100 European and international experts. OAN SININIroN AND COMIN Antimicrobial resistance of microorganisms reported in healthcare-associated infections (HAIS) 34.8% 26.7% 1.5% Citrobacter spp. 23.5% 4.6% Morganella spp. 3.6% 53% 19.3% Escherichia coli Klebsiella spp. 40.5% 3.5% Third-generation cephalosporin resistance Enterobacter spp. 10.2% Enterococcus spp. Meticillin resistance (MRSA) Vancomycin resistance (VRE) 41.2% Carbapenem resistance Staphylococcus aureus 81.2% 23.1% Acinetobacter baumannii 6.6% Proteus spp. 31.8% 25.9% 1.3% Serratia spp. Pseudomonas aeruginosa